The Morrison lab is dedicated to advancing neuromodulation therapies for patients with neuropsychiatric conditions such as Parkinson’s disease and obsessive-compulsive disorder. We extract quantitative information from brain MRI images to study and predict patients’ neural and clinical responses to brain stimulation. Ultimately, our goal is to develop MRI-based decision-support tools for clinicians who administer neuromodulation therapies. Navigate our ongoing projects, funding, and publications using the panel on the right.